Steven P. Cobourn - Jan 31, 2025 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Chief Financial Officer
Signature
/s/ Steven P. Cobourn
Stock symbol
NXTC
Transactions as of
Jan 31, 2025
Transactions value $
$0
Form type
4
Date filed
2/3/2025, 06:22 PM
Previous filing
Apr 2, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Employee Stock Option (Right to Buy) Award $0 +117K $0.00 117K Jan 31, 2025 Common Stock 117K $0.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One fourth of the option vests on January 31, 2026. The remainder vests in 36 monthly installments beginning on February 28, 2026.